Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer
NCT02934828
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
230
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Neoadjuvant Chemotherapy
DRUG:
postoperative chemotherapy
Sponsor
Chinese Academy of Medical Sciences